Literature DB >> 19959473

Modes of calreticulin recruitment to the major histocompatibility complex class I assembly pathway.

Natasha Del Cid1, Elise Jeffery, Syed Monem Rizvi, Ericca Stamper, Larry Robert Peters, William Clay Brown, Chester Provoda, Malini Raghavan.   

Abstract

Major histocompatibility complex (MHC) class I molecules are ligands for T-cell receptors of CD8(+) T cells and inhibitory receptors of natural killer cells. Assembly of the heavy chain, light chain, and peptide components of MHC class I molecules occurs in the endoplasmic reticulum (ER). Specific assembly factors and generic ER chaperones, collectively called the MHC class I peptide loading complex (PLC), are required for MHC class I assembly. Calreticulin has an important role within the PLC and induces MHC class I cell surface expression, but the interactions and mechanisms involved are incompletely understood. We show that interactions with the thiol oxidoreductase ERp57 and substrate glycans are important for the recruitment of calreticulin into the PLC and for its functional activities in MHC class I assembly. The glycan and ERp57 binding sites of calreticulin contribute directly or indirectly to complexes between calreticulin and the MHC class I assembly factor tapasin and are important for maintaining steady-state levels of both tapasin and MHC class I heavy chains. A number of destabilizing conditions and mutations induce generic polypeptide binding sites on calreticulin and contribute to calreticulin-mediated suppression of misfolded protein aggregation in vitro. We show that generic polypeptide binding sites per se are insufficient for stable recruitment of calreticulin to PLC substrates in cells. However, such binding sites could contribute to substrate stabilization in a step that follows the glycan and ERp57-dependent recruitment of calreticulin to the PLC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19959473      PMCID: PMC2836057          DOI: 10.1074/jbc.M109.085407

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Dimerization and oligomerization of the chaperone calreticulin.

Authors:  Charlotte S Jørgensen; L Rebekka Ryder; Anne Steinø; Peter Højrup; Jesper Hansen; N Helena Beyer; Niels H H Heegaard; Gunnar Houen
Journal:  Eur J Biochem       Date:  2003-10

2.  A new vector for high-throughput, ligation-independent cloning encoding a tobacco etch virus protease cleavage site.

Authors:  Lucy Stols; Minyi Gu; Lynda Dieckman; Rosemarie Raffen; Frank R Collart; Mark I Donnelly
Journal:  Protein Expr Purif       Date:  2002-06       Impact factor: 1.650

3.  TROSY-NMR reveals interaction between ERp57 and the tip of the calreticulin P-domain.

Authors:  Eva-Maria Frickel; Roland Riek; Ilian Jelesarov; Ari Helenius; Kurt Wuthrich; Lars Ellgaard
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-12       Impact factor: 11.205

4.  Assembly and antigen-presenting function of MHC class I molecules in cells lacking the ER chaperone calreticulin.

Authors:  Bin Gao; Raju Adhikari; Mark Howarth; Kimitoshi Nakamura; Marielle C Gold; Ann B Hill; Rai Knee; Marek Michalak; Tim Elliott
Journal:  Immunity       Date:  2002-01       Impact factor: 31.745

5.  The metal ion binding properties of calreticulin modulate its conformational flexibility and thermal stability.

Authors:  Z Li; W F Stafford; M Bouvier
Journal:  Biochemistry       Date:  2001-09-18       Impact factor: 3.162

6.  Impaired assembly yet normal trafficking of MHC class I molecules in Tapasin mutant mice.

Authors:  A G Grandea; T N Golovina; S E Hamilton; V Sriram; T Spies; R R Brutkiewicz; J T Harty; L C Eisenlohr; L Van Kaer
Journal:  Immunity       Date:  2000-08       Impact factor: 31.745

7.  A major role for tapasin as a stabilizer of the TAP peptide transporter and consequences for MHC class I expression.

Authors:  Natalio Garbi; Neeraj Tiwari; Frank Momburg; Günter J Hämmerling
Journal:  Eur J Immunol       Date:  2003-01       Impact factor: 5.532

8.  Identification and characterization of structural domains of human ERp57: association with calreticulin requires several domains.

Authors:  Laura Silvennoinen; Johanna Myllyharju; Margherita Ruoppolo; Stefania Orrù; Marianna Caterino; Kari I Kivirikko; Peppi Koivunen
Journal:  J Biol Chem       Date:  2004-01-19       Impact factor: 5.157

9.  Major histocompatibility complex class I molecules expressed with monoglucosylated N-linked glycans bind calreticulin independently of their assembly status.

Authors:  Pamela A Wearsch; Claude A Jakob; Antonio Vallin; Raymond A Dwek; Pauline M Rudd; Peter Cresswell
Journal:  J Biol Chem       Date:  2004-03-31       Impact factor: 5.157

10.  Mutational analysis provides molecular insight into the carbohydrate-binding region of calreticulin: pivotal roles of tyrosine-109 and aspartate-135 in carbohydrate recognition.

Authors:  Mili Kapoor; Lars Ellgaard; Jayashree Gopalakrishnapai; Christiane Schirra; Emiliano Gemma; Stefan Oscarson; Ari Helenius; Avadhesha Surolia
Journal:  Biochemistry       Date:  2004-01-13       Impact factor: 3.162

View more
  31 in total

1.  The polypeptide binding conformation of calreticulin facilitates its cell-surface expression under conditions of endoplasmic reticulum stress.

Authors:  Elise Jeffery; Larry Robert Peters; Malini Raghavan
Journal:  J Biol Chem       Date:  2010-11-12       Impact factor: 5.157

2.  Endoplasmic reticulum calcium depletion impacts chaperone secretion, innate immunity, and phagocytic uptake of cells.

Authors:  Larry Robert Peters; Malini Raghavan
Journal:  J Immunol       Date:  2011-06-13       Impact factor: 5.422

3.  Contributions of the Lectin and Polypeptide Binding Sites of Calreticulin to Its Chaperone Functions in Vitro and in Cells.

Authors:  Ronnie Lum; Samar Ahmad; Seo Jung Hong; Daniel C Chapman; Guennadi Kozlov; David B Williams
Journal:  J Biol Chem       Date:  2016-07-13       Impact factor: 5.157

4.  Structural and functional relationships between the lectin and arm domains of calreticulin.

Authors:  Cosmin L Pocanschi; Guennadi Kozlov; Ulf Brockmeier; Achim Brockmeier; David B Williams; Kalle Gehring
Journal:  J Biol Chem       Date:  2011-06-07       Impact factor: 5.157

5.  Calreticulin is a thermostable protein with distinct structural responses to different divalent cation environments.

Authors:  Sanjeeva J Wijeyesakere; Ari A Gafni; Malini Raghavan
Journal:  J Biol Chem       Date:  2010-12-22       Impact factor: 5.157

6.  Regulation of calreticulin-major histocompatibility complex (MHC) class I interactions by ATP.

Authors:  Sanjeeva Joseph Wijeyesakere; Jessica K Gagnon; Karunesh Arora; Charles L Brooks; Malini Raghavan
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-29       Impact factor: 11.205

7.  Distinct functions for the glycans of tapasin and heavy chains in the assembly of MHC class I molecules.

Authors:  Syed Monem Rizvi; Natasha Del Cid; Lonnie Lybarger; Malini Raghavan
Journal:  J Immunol       Date:  2011-01-24       Impact factor: 5.422

8.  Distinct assembly profiles of HLA-B molecules.

Authors:  Syed Monem Rizvi; Nasir Salam; Jie Geng; Ying Qi; Jay H Bream; Priya Duggal; Shehnaz K Hussain; Jeremy Martinson; Steven M Wolinsky; Mary Carrington; Malini Raghavan
Journal:  J Immunol       Date:  2014-04-30       Impact factor: 5.422

9.  Mutant calreticulin-expressing cells induce monocyte hyperreactivity through a paracrine mechanism.

Authors:  Michael R Garbati; Catherine A Welgan; Sally H Landefeld; Laura F Newell; Anupriya Agarwal; Jennifer B Dunlap; Tapan K Chourasia; Hyunjung Lee; Johannes Elferich; Elie Traer; Rogan Rattray; Michael J Cascio; Richard D Press; Grover C Bagby; Jeffrey W Tyner; Brian J Druker; Kim-Hien T Dao
Journal:  Am J Hematol       Date:  2016-02       Impact factor: 10.047

10.  Oxidative stress-induced calreticulin expression and translocation: new insights into the destruction of melanocytes.

Authors:  Yajun Zhang; Ling Liu; Liang Jin; Xiuli Yi; Erle Dang; Yang Yang; Chunying Li; Tianwen Gao
Journal:  J Invest Dermatol       Date:  2013-06-14       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.